Causes
The primary cause of this condition is a mutation in the DNA of B-cells, which are a type of white blood cell responsible for fighting infections. These mutations cause the cells to grow and divide uncontrollably, accumulating in the lymph nodes or other organs. The exact reason these mutations occur is often unknown.

Risk Factors
Several factors may increase the likelihood of developing this lymphoma, although having a risk factor does not mean one will get the disease. Known contributors include:

• Age over 60 years.
• Male gender.
• Weakened immune system due to HIV/AIDS or organ transplant medications.
• Autoimmune diseases such as rheumatoid arthritis, lupus, or Sjogren's syndrome.
• Certain viral infections like Epstein-Barr virus or Hepatitis C.
• Previous treatment with radiation or chemotherapy.

Prevention
There is no known way to prevent most cases of this condition since the underlying DNA changes often happen sporadically. Strategies to reduce risk focus on managing modifiable factors, such as treating HIV or Hepatitis C infections and minimizing exposure to radiation or toxic chemicals when possible. Routine health maintenance is important, but specific prevention methods for this cancer do not currently exist.

Signs and Symptoms
The most common sign is a painless swelling of the lymph nodes in the neck, armpit, or groin. Clinically meaningful symptoms that may indicate more aggressive or systemic disease include:

• Unexplained fever that persists.
• Drenching night sweats that soak through clothing.
• Unexplained weight loss of more than 10 percent of body weight.
• Severe fatigue or exhaustion.
• Loss of appetite.
• Pain in the chest, abdomen, or bones if the lymphoma presses on these areas.

Diagnostic Tests
Clinicians use a combination of exams and tests to identify the condition. A physical exam checks for swollen nodes and enlarged organs like the spleen. The definitive diagnosis is made through a biopsy, where a surgeon removes a lymph node or a piece of tissue to be examined under a microscope. Additional tests include:

• Blood tests to check blood cell counts and lactate dehydrogenase (LDH) levels.
• PET/CT scans to determine where the cancer is located in the body.
• Bone marrow biopsy to see if the lymphoma has spread to the bone marrow.
• Lumbar puncture (spinal tap) if there is risk of spread to the brain or spinal cord.

Differential Diagnosis
Doctors must distinguish this condition from other causes of swollen lymph nodes, such as bacterial or viral infections. It is also differentiated from other types of cancers, including Hodgkin lymphoma, follicular lymphoma, and metastatic cancers that have spread from other organs.

Medications and Therapies
The standard treatment is a combination of chemotherapy and immunotherapy, most commonly a regimen known as R-CHOP. This includes monoclonal antibodies that target cancer cells along with chemotherapy drugs that kill rapidly dividing cells. For patients who do not respond to initial therapy or who relapse, advanced options like CAR T-cell therapy, antibody-drug conjugates, or bispecific antibodies may be used.

Procedures
Radiation therapy is sometimes used for patients with localized disease or to relieve pain from large tumors. In certain cases of relapsed disease, a stem cell transplant may be recommended to replace diseased bone marrow with healthy stem cells after high-dose chemotherapy.

Monitoring and Management
During and after treatment, patients require regular monitoring with blood tests and imaging scans to check for response and potential side effects. Management also involves preventing infections, as treatment suppresses the immune system. Patients are often advised to maintain good hygiene and avoid crowds.

When to Seek Medical Care
Patients should contact their healthcare provider immediately if they experience signs of infection such as a fever over 100.4°F (38°C), chills, or shortness of breath. Emergency care should be sought for severe chest pain, confusion, or difficulty breathing. Routine follow-up is essential to monitor for recurrence, especially in the first two years after treatment.

Severity and Course
This condition is classified as an aggressive lymphoma, meaning it grows and spreads quickly if left untreated. However, it is also highly responsive to treatment. Without therapy, life expectancy is short, but with modern treatment, the disease course can be altered significantly, leading to a cure in many cases.

Prognosis and Life Expectancy
The prognosis is generally favorable, with approximately 60% to 70% of patients being cured with first-line therapy. Factors that influence the outcome include the patient's age, the stage of the disease, blood LDH levels, and general performance status. Patients who achieve complete remission and stay cancer-free for two years have a life expectancy similar to the general population.

Complications
Possible complications include side effects from treatment such as heart damage, nerve damage (neuropathy), or secondary cancers later in life. In the short term, patients are at high risk for serious infections due to low white blood cell counts. Long-term follow-up is necessary to manage these potential health risks.

Impact on Activities
Treatment can be physically demanding, often causing fatigue that limits the ability to work or attend school full-time. Patients may need to adjust their schedules to allow for rest and medical appointments. Avoiding potential sources of infection is often necessary, which may limit social interactions during active treatment.

Mental and Emotional Health
A diagnosis of aggressive cancer causes significant stress and anxiety. Fear of recurrence is common even after successful treatment. Many patients find it helpful to join support groups or seek counseling to develop coping strategies for the emotional ups and downs of the cancer journey.

Questions to Ask Your Healthcare Provider
Patients can better understand their care by asking specific questions:

• What is the specific subtype and stage of my lymphoma?
• What is the goal of my treatment—is it to cure the disease or control symptoms?
• What are the immediate and long-term side effects of the proposed treatment?
• How will this treatment affect my fertility and ability to have children?
• Am I eligible for any clinical trials?
• How often will I need follow-up scans and check-ups after treatment ends?

Q: Is diffuse large B-cell lymphoma curable?
A: Yes, it is potentially curable. A majority of patients achieve complete remission with standard chemotherapy and immunotherapy treatments.

Q: Is this type of cancer hereditary?
A: No, it is generally not hereditary. The DNA mutations that cause this lymphoma usually happen during a person's lifetime and are not passed down to children.

Q: How long does treatment usually take?
A: A typical course of treatment involves chemotherapy cycles given every few weeks, usually lasting for a total of about four to six months.

Q: Is it contagious?
A: No, lymphoma is not contagious. You cannot catch it from or spread it to another person.

Q: Can stress cause this condition?
A: There is no scientific evidence that stress causes lymphoma. It is caused by biological changes in blood cells.